LSTR in Chevron Osteotomy
Launched by THE METHODIST HOSPITAL RESEARCH INSTITUTE · Jun 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a specific type of surgery for bunions, called a Chevron osteotomy, to see if adding a procedure called lateral soft tissue release (LSTR) improves the results. The main goal is to find out if combining these two methods helps correct the bunion better without causing more problems. The study will involve 200 adults over 18 years old who have mild to moderate bunions that could benefit from this surgery. Participants will be randomly assigned to either the standard surgery or the surgery with the added LSTR and will be monitored with surveys and X-rays at different times after the operation.
To be eligible for this trial, you need to be over 18 and have mild to moderate bunions that can be treated with a Chevron osteotomy. Unfortunately, if you have severe bunions, certain health issues, or if you’ve had previous bunion surgery, you won't be able to participate. This study is currently recruiting participants, and it’s a great opportunity for those who qualify to potentially benefit from improved surgery outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over the age of 18 years old
- • Have mild to moderate bunions that are determined to benefit from Chevron osteotomies
- Exclusion Criteria:
- • Under the age of 18
- • Connective tissue disease
- • Juvenile bunions
- • Severe bunions
- • Revision surgery
About The Methodist Hospital Research Institute
The Methodist Hospital Research Institute (MHRI) is a leading clinical research organization dedicated to advancing medical science through innovative research and collaboration. Affiliated with the Methodist Hospital system, MHRI focuses on a broad spectrum of clinical trials, aiming to translate cutting-edge discoveries into effective therapies that enhance patient care. With a commitment to ethical standards and patient safety, the institute fosters partnerships between researchers, clinicians, and industry stakeholders, driving progress in fields such as cancer, cardiology, neurology, and more. Through its robust infrastructure and multidisciplinary approach, MHRI strives to improve health outcomes and contribute to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported